Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373143 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Abstract
A series of β-aminoacyl containing thiazolidine derivatives was synthesized and evaluated for their ability to inhibit DPP-IV. Several thiazolidine derivatives with an acid moiety were found to be potent DPP-IV inhibitors. Among them, compound 2da is the most active in this series with an IC50 value of 1 nM, and it showed excellent selectivity over DPP-IV related enzymes including DPP-2, DPP-8, and DPP-9. Compound 2da is chemically and metabolically stable, and showed no CYP inhibition, hERG binding or cytotoxicity. Compound 2db, an ester prodrug of 2da, showed good in vivo DPP-IV inhibition after oral administration in rat and dog models.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Woul Seong Park, Seung Kyu Kang, Mi Ae Jun, Mi Sik Shin, Ki Young Kim, Sang Dal Rhee, Myung Ae Bae, Min Sun Kim, Kwang Rok Kim, Nam Sook Kang, Sung-eun Yoo, Jie Oh Lee, Dong Hyun Song, Peter Silinski, Stephen Edward Schneider, Jin Hee Ahn, Sung Soo Kim,